Enabling discovery
Visual data intelligence for pharmaceutical and biomedical applications – powered by AI.
One ecosystem, four powerful products
We provide a full-lifecycle suite for biomedical drug discovery that combines interactive visual analytics with AI/LLM-supported intelligence.
A suite of specialized apps for scientific discovery, disease understanding, and lead development.
Explore Aevidence→A visual analysis tool to explore, filter, rank, and prioritize targets and biomarkers.
Explore Ordino→A curated database of 80+ public repositories acting as a single source of truth.
Explore visynData→Reusable, domain-specific visual building blocks that AI agents select and assemble into interactive applications.
Explore visynAgents→A suite of specialized apps for scientific discovery, disease understanding, and lead development.
Explore Aevidence→Latest news and events
Our latest LinkedIn posts are shown via the service Elfsight. Loading them transfers your IP address to Elfsight (Armenia) and sets cookies. Read more in our privacy policy.
Customer and user voices
Collaborating with datavisyn was a very rewarding experience for us. Thanks to their unique agile setup, we were able to roll out innovative and impactful visual analytics portals that we jointly created in a truly time-efficient manner.
datavisyn provides an excellent combination of know-how in visual data science and bioinformatics, and they have a highly professional and agile software engineering team. It is a great pleasure working with them.
The platform has saved considerable time when exploring gene–disease associations and identifying available datasets across the company. Having a centralized, accessible entry point eliminates the friction of searching through scattered sources, making our daily research workflows far more efficient.
Multiomics Analysis Expert, Big Pharma (US)
Bayer’s partnership with datavisyn has reshaped how our research teams work with complex biomedical and omics data. Through interactive visual analytics tools powered by AI, researchers can explore and evaluate targets with far greater clarity. That clarity translates directly into faster, more confident decision-making for our pipeline project. Today, Datavisyn stands as one of the most trusted digital technology partners in our target discovery work.
Awarded for turning research into production software
In 2024 the EY ScaleUp Awards named datavisyn Spin-off of the Year and a finalist in Biotech & Health, recognizing the path from university research to production software used in pharmaceutical R&D.
